A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Clinical trial NCT03336216 · COMPLETED
Trial details
- NCT number
- NCT03336216
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2023-06-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.